LGVN
LGVN
NASDAQ · Biotechnology

Longeveron Inc-A

$2.42
-0.55 (-18.52%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +1,044.2% upside
Low Target $21.92
Average Target $27.69
High Target $40.08
Current Price $2.42
Current
$2.42
Target
$27.69
$21.92 $27.69 avg $40.08
Scenario Analysis
Bear Case
$21.92
805.8%
Low target
Base Case
$27.69
+1,044.2%
Avg target
Bull Case
$40.08
+1,556.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$12.30
-80.3% from high
52-Week Low
$1.31
+84.7% from low
Target vs 52W High
$27.69
+125.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -54.8%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.2%